Deora v. NantHealth, Inc.
NantHealth, Inc. Securities Litigation
2:17-cv-01825-TJH-MRW

Welcome to the NantHealth, Inc. Securities Litigation Website

The information contained on this website is only a summary of the information presented in more detail in the notice.

 

If you bought NantHealth, Inc., common stock between June 1, 2016, and May 1, 2017, you could benefit from a class action settlement.

NantHealth, Inc., has agreed to pay $16,500,000, to resolve a class action lawsuit on behalf of investors who bought NantHealth common stock between June 1, 2016, and May 1, 2017 (the Class Period). 

The settlement resolves a lawsuit over whether NantHealth misled investors by overstating the market demand for NantHealth’s genetic sequencing services in the company’s registration statement, IPO prospectus, and other public statements. The settlement avoids the costs and risks to you from continuing the lawsuit; pays money to investors like you; and releases NantHealth from liability.  

Court-appointed lawyers for investors will ask the Court for attorneys’ fees (up to $4.125 million), cost reimbursements (up to $375,000), and a compensatory award (up to $25,000) to the Class Representative. If these requests are granted, and after settlement administration expenses are paid, an estimated $11.725 million will remain to be paid to Class Members.

NantHealth and the other Defendants are entering this settlement solely to eliminate the uncertainty, burden and expense of further protracted litigation.  Defendants have denied and continue to deny all of the wrongful conduct alleged in this case.

The two sides disagree on how much money could have been won if investors won at trial. 

Your legal rights are affected whether you act or don’t act. Read the notice carefully.

 

YOUR LEGAL RIGHTS AND OPTIONS IN THE SETTLEMENT:

SUBMIT A CLAIM FORM BY MAY 22, 2020

The only way to get a payment.

EXCLUDE YOURSELF BY MAY 22, 2020

Get no payment. This is the only option that allows you to ever be part of any other lawsuit against NantHealth and its executives about the legal claims in this case.

OBJECT BY MAY 22, 2020

Write to the Court about why you don’t like the settlement.

GO TO A HEARING

Ask to speak in Court about the fairness of the settlement.

DO NOTHING.

Get no payment. Give up rights.

 

These rights and options—and the deadlines to exercise them—are explained in the notice.

The Court in charge of this case still must decide whether to approve the settlement.  Payments will be made if the Court approves the settlement and after appeals (if any) are resolved. Please be patient.

How do I get more information?

Detailed information about the Action and the Settlement is contained in the notice available for download on the Important Documents page of this website. Additional information can also be obtained by contacting the Claims Administrator by calling toll-free 1-844-975-1779, emailing info@NantHealthSecuritiesLitigation.com or mailing a letter to:

 

NantHealth, Inc., Securities Litigation
c/o JND Legal Administration
P.O. Box 91125
Seattle, WA 98111

 

Inquiries should NOT be directed to the Court or the Clerk of the Court.

For More Information

Visit this website often to get the most up-to-date information.

Mail

NantHealth, Inc., Securities Litigation
c/o JND Legal Administration
P.O. Box 91125
Seattle, WA 98111